| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8447955 | European Journal of Cancer | 2010 | 6 Pages |
Abstract
The observed safety profile suggests no benefit over standard cisplatin formulations and LiPlaCis will require reformulation to enable further development.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Maja J.A. de Jonge, Marije Slingerland, Walter J. Loos, Erik A.C. Wiemer, Herman Burger, Ron H.J. Mathijssen, Judith R. Kroep, Margret A.G. den Hollander, Diane van der Biessen, Mei-Ho Lam, Jaap Verweij, Hans Gelderblom,